• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES COMMANDER DELIVERY SYSTEM; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES COMMANDER DELIVERY SYSTEM; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED Back to Search Results
Model Number 9750CM29A
Device Problem Material Deformation (2976)
Patient Problem Insufficient Information (4580)
Event Date 12/05/2023
Event Type  malfunction  
Event Description
During an off-label tavr case for pure ai using a 29mm sapien 3 valve via subclavian approach, +7cc to start and the valve began to migrate into the left ventricle shortly after.Several cc's were added after to secure the valve more and the balloon burst.The pressures dropped quickly after.A new valve/system was quickly prepped but was never implanted as it was determined that there was a rupture and the patient wasn't a candidate for opening the chest.The patient passed away.
 
Manufacturer Narrative
This is one of two manufacturer reports being submitted for this case.Please reference related manufacturer report no: 2015691-2023-18503.The investigation is ongoing.H3 other text : device will not be returned.
 
Manufacturer Narrative
Correction to h6; type of investigation, investigation findings, investigation conclusion.The 29mm commander delivery system (ds) was not available for examination.Due to the unavailability of the complaint device, engineering could not perform any visual inspection, functional testing, or dimensional analysis.The following instructions for use (ifu) were reviewed: the commander delivery system and the device procedural training manual.Based on this review, no ifu training deficiencies were identified.A review of edwards lifesciences risk management documentation was performed for this case.The reported event is an anticipated risk of the transcatheter heart valve procedure, additional assessment of the failure mode is not required at this time.The complaint of balloon burst was unable to be confirmed as no procedural imagery or device was provided for evaluation.Due to the unavailability of the device, engineering was unable to perform any visual, functional, or dimensional analysis; therefore, a manufacturing non-conformance was unable to be determined.Due to the unavailability of the device lot number, a review of the dhr and lot history was unable to be performed.A review of the ifu and training manuals revealed no deficiencies.The reported event states, "during an off-label tavr case for pure ai using a 29mm sapien 3 valve via subclavian approach, +7cc to start and the valve began to migrate into the left ventricle shortly after.Several cc's were added after to secure the valve more and the balloon burst".While the balloons are sufficiently designed and tested to ensure the burst pressure is at or above the rated burst pressure, there are several factors that could result in balloon burst such as calcification, over-inflation, and interaction with previously implanted valve/stent.In this case, additional volume (+7cc) was initially added, and then several cc's were used to secure the valve.The prescribed nominal inflation volume is provided in the ifu.Based on the provided information, it is possible that the balloon was overinflated, subjecting the balloon to pressures high enough to cause the balloon to burst.While a conclusive root cause was unknown, available information suggests that procedural factors (over-inflation) may have contributed to the balloon burst.Complaint histories for all reported events are reviewed against trending control limits monthly, and any excursions above the control limits are assessed and documented as part of this monthly review.As such, neither a product risk assessment nor corrective or preventative actions are required at this time.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COMMANDER DELIVERY SYSTEM
Type of Device
AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED
Manufacturer (Section D)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
Manufacturer (Section G)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
Manufacturer Contact
renee van dorne
1 edwards way
irvine, CA 92614
9492506385
MDR Report Key18352686
MDR Text Key331062515
Report Number2015691-2023-18516
Device Sequence Number1
Product Code NPT
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P140031
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 02/05/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number9750CM29A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 12/05/2023
Initial Date FDA Received12/18/2023
Supplement Dates Manufacturer Received02/02/2024
Supplement Dates FDA Received02/05/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient SexMale
-
-